| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | Uses of FAHD1 | US15523507 | 2015-10-30 | US20170312343A1 | 2017-11-02 | Eva Albertini; Elisabeth Mayr; Andrea Taferner; Haymo Pircher; Pidder Jansen-Duerr; Susanne von Grafenstein; Christian Kramer; Klaus R. Liedl; Thomas Diener; Christina Metzger |
| The present invention provides FAHD1 for use in a method for the treatment or prevention of aberrations of the energy metabolism of the nervous system, pancreas, kidney, liver, muscles or adipose tissue. Further, a method of decarboxylating an organic compound is provided, which uses FAHD1 to decarboxylate the organic compound. Additionally, a method and a kit for identifying inhibitors of FAHD1 are provided. | ||||||
| 2 | USES OF FAHD1 | EP15788404.0 | 2015-10-30 | EP3212178A1 | 2017-09-06 | ALBERTINI, Eva; MAYR, Elisabeth; TAFERNER, Andrea; PIRCHER, Haymo; JANSEN-DUERR, Pidder; VON GRAFENSTEIN, Susanne; KRAMER, Christian; LIEDL, Klaus R.; DIENER, Thomas; METZGER, Christina |
| The present invention provides FAHD1 for use in a method for the treatment or prevention of aberrations of the energy metabolism of the nervous system, pancreas, kidney, liver, muscles or adipose tissue. Further, a method of decarboxylating an organic compound is provided, which uses FAHD1 to decarboxylate the organic compound. Additionally, a method and a kit for identifying inhibitors of FAHD1 are provided. | ||||||
QQ群二维码
意见反馈
意见反馈